Cell inspired delivery system equipped with natural membrane structures in applications for rescuing ischemic stroke

被引:0
作者
Zhu, Anran [1 ,2 ]
Jiang, Yingyu [1 ,2 ]
Pan, Longxiang [1 ,2 ]
Li, Jiale [1 ,2 ]
Huang, Yao [1 ,2 ]
Shi, Minghui [1 ,2 ]
Di, Liuqing [1 ,2 ]
Wang, Lei [3 ,4 ,5 ]
Wang, Ruoning [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Prov TCM Engn Technol Res Ctr High Efficie, Sch Pharm, Nanjing 210023, Peoples R China
[2] Nanjing Univ Chinese Med, State Key Lab Technol Chinese Med Pharmaceut Proc, Nanjing 210023, Peoples R China
[3] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[4] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China
[5] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Natural membrane; Brain targeting; Drug delivery; Nanotechnology; Ischemic stroke; BLOOD-BRAIN-BARRIER; ASTROCYTE-DERIVED EXOSOMES; MESENCHYMAL STEM-CELLS; TARGETED DRUG-DELIVERY; EXTRACELLULAR VESICLES; CEREBRAL-ISCHEMIA; GLYCOPROTEIN-IB; NITRIC-OXIDE; COATED NANOPARTICLES; SUPEROXIDE-DISMUTASE;
D O I
10.1016/j.jconrel.2024.11.013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Ischemic stroke (IS), accounting for 87 % of stroke incidences, constitutes a paramount health challenge owing to neurological impairments and irreversible tissue damage arising from cerebral ischemia. Chief among therapeutic obstacles are the restrictive penetration of the blood-brain barrier (BBB) and insufficient targeting precision, hindering the accumulation of drugs in ischemic brain areas. Motivated by the remarkable capabilities of natural membrane-based delivery vehicles in achieving targeted delivery and traversing the BBB, thanks to their biocompatible architecture and bioactive components, numerous membrane-engineered systems such as cells, cell membranes and extracellular vesicles have emerged as promising platforms to augment IS treatment efficacy with the help of nanotechnology. This review consolidates the primary pathological manifestations following IS, elucidates the unique functionalities of natural membrane drug delivery systems (DDSs) with nanotechnology, as well as delineates the structural characteristics of various natural membranes alongside rational design strategies employed. The review illuminates both the potential and challenges encountered when employing natural membrane DDSs in IS drug therapy, offering fresh perspectives and insights for devising efficacious and practical delivery systems tailored to IS intervention.
引用
收藏
页码:54 / 80
页数:27
相关论文
共 299 条
  • [1] ULTRASTRUCTURE OF INTRACELLULAR AND EXTRACELLULAR VESICLES, MEMBRANES, AND MYELIN FIGURES PRODUCED BY OCHROMONAS-DANICA
    AARONSON, S
    BEHRENS, U
    ORNER, R
    HAINES, TH
    [J]. JOURNAL OF ULTRASTRUCTURE RESEARCH, 1971, 35 (5-6): : 418 - &
  • [2] Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake
    Abels, Erik R.
    Breakefield, Xandra O.
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (03) : 301 - 312
  • [3] Modulating Astrocyte Transition after Stroke to Promote Brain Rescue and Functional Recovery: Emerging Targets Include Rho Kinase
    Abeysinghe, Hima Charika S.
    Phillips, Ellie L.
    Chin-Cheng, Heung
    Beart, Philip M.
    Roulston, Carli L.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03):
  • [4] How location and cellular signaling combine to activate the NLRP3 inflammasome
    Akbal, Anil
    Dernst, Alesja
    Lovotti, Marta
    Mangan, Matthew S. J.
    McManus, Roisin M.
    Latz, Eicke
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1201 - 1214
  • [5] Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
    Alvarez-Erviti, Lydia
    Seow, Yiqi
    Yin, HaiFang
    Betts, Corinne
    Lakhal, Samira
    Wood, Matthew J. A.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (04) : 341 - U179
  • [6] Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion
    Arumugam, TV
    Salter, JW
    Chidlow, JH
    Ballantyne, CM
    Kevil, CG
    Granger, DN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (06): : H2555 - H2560
  • [7] The blood-brain barrier: an overview - Structure, regulation, and clinical implications
    Ballabh, P
    Braun, A
    Nedergaard, M
    [J]. NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 1 - 13
  • [8] Human placental mesenchymal stem cells improve stroke outcomes via extracellular vesicles-mediated preservation of cerebral blood flow
    Barzegar, Mansoureh
    Wang, Yuping
    Eshaq, Randa S.
    Yun, J. Winny
    Boyer, Christen J.
    Cananzi, Sergio G.
    White, Luke A.
    Chernyshev, Oleg
    Kelley, Roger E.
    Minagar, Alireza
    Stokes, Karen Y.
    Lu, Xiao-Hong
    Alexander, Jonathan S.
    [J]. EBIOMEDICINE, 2021, 63
  • [9] European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
    Berge, Eivind
    Whiteley, William
    Audebert, Heinrich
    Marchis, Gian Marco De
    Fonseca, Ana Catarina
    Padiglioni, Chiara
    Ossa, Natalia Perez de la
    Strbian, Daniel
    Tsivgoulis, Georgios
    Turc, Guillaume
    [J]. EUROPEAN STROKE JOURNAL, 2021, 6 (01) : I - LXII
  • [10] Pathophysiology of Blood-Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery
    Bernardo-Castro, Sara
    Sousa, Joao Andre
    Bras, Ana
    Cecilia, Carla
    Rodrigues, Bruno
    Almendra, Luciano
    Machado, Cristina
    Santo, Gustavo
    Silva, Fernando
    Ferreira, Lino
    Santana, Isabel
    Sargento-Freitas, Joao
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11